Oxidative stress, a common molecular pathway for kidney disease: Role of the redox enzyme p66Shc

References

• Vostalova J, Galandakova A, Strebl P, et al. Oxidative stress in kidney disease patients. Vnitr Lek. 2012;58:202–207
   Google Scholar
• Menini S, Amadio L, Oddi G, et al. Deletion of p66Shc longevity gene protects against experimental diabetic glomerulopathy by preventing diabetes-induced oxidative stress. Diabetes. 2006;55:1642–1650
   PubMed Web of Science ®Google Scholar
• Luzi L, Confalonieri S, Di Fiore PP, Pelicci PG. Evolution of Shc functions from nematode to human. Curr Opin Genet Dev. 2000;10:668–674
   PubMed Web of Science ®Google Scholar
• Pawson T, Scott JD. Signaling through scaffold, anchoring, and adaptor proteins. Science. 1997;278:2075–2080
   PubMed Web of Science ®Google Scholar
• Giorgio M, Migliaccio E, Orsini F, et al. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell. 2005;122:221–233
   PubMed Web of Science ®Google Scholar
• Bonfini L, Migliaccio E, Pelicci G, et al. Not all Shc's roads lead to Ras. Trends Biochem Sci. 1996;21:257–261
   PubMed Web of Science ®Google Scholar
• Chakraborti T, Das S, Mondal M, et al. Oxidant, mitochondria and calcium: an overview. Cell Signal. 1999;11:77–85
   PubMed Web of Science ®Google Scholar
• Piantadosi CA, Suliman HB. Redox regulation of mitochondrial biogenesis. Free Radic Biol Med. 2012;53:2043–2053
   PubMed Web of Science ®Google Scholar
• Galimov ER. The role of p66shc in oxidative stress and apoptosis. Acta Naturae. 2010;2:44–51
   PubMed Web of Science ®Google Scholar
• Khanday FA, Santhanam L, Kasuno K, et al. Sos-mediated activation of rac1 by p66shc. J Cell Biol. 2006;172:817–822
   PubMedGoogle Scholar
• Wu Z, Rogers B, Kachi S, et al. Reduction of p66Shc suppresses oxidative damage in retinal pigmented epithelial cells and retina. J Cell Physiol. 2006;209:996–1005
   PubMed Web of Science ®Google Scholar
• Koch OR, Fusco S, Ranieri SC, et al. Role of the life span determinant P66(shcA) in ethanol-induced liver damage. Lab Invest. 2008;88:750–760
   PubMed Web of Science ®Google Scholar
• Berniakovich I, Trinei M, Stendardo M, et al. p66Shc-generated oxidative signal promotes fat accumulation. J Biol Chem. 2008;283:34283–34293
   Google Scholar
• Pinton P, Rimessi A, Marchi S, et al. Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science. 2007;315:659–663
   PubMed Web of Science ®Google Scholar
• Liesa M, Palacin M, Zorzano A. Mitochondrial dynamics in mammalian health and disease. Physiol Rev. 2009;89:799–845
   PubMed Web of Science ®Google Scholar
• Otera H, Mihara K. Molecular mechanisms and physiologic functions of mitochondrial dynamics. J Biochem. 2011;149:241–251
   PubMed Web of Science ®Google Scholar
• Zhan M, Brooks C, Liu F, et al. Mitochondrial dynamics: regulatory mechanisms and emerging role in renal pathophysiology. Kidney Int. 2013;83:568–581
   PubMed Web of Science ®Google Scholar
• Small DM, Coombes JS, Bennett N, et al. Oxidative stress, anti-oxidant therapies and chronic kidney disease. Nephrology (Carlton). 2012;17:311–321
   PubMed Web of Science ®Google Scholar
• Raffaello A, Rizzuto R. Mitochondrial longevity pathways. Biochim Biophys Acta. 2011;1813:260–268
   PubMed Web of Science ®Google Scholar
• Su K, Bourdette D, Forte M. Genetic inactivation of mitochondria-targeted redox enzyme p66ShcA preserves neuronal viability and mitochondrial integrity in response to oxidative challenges. Front Physiol. 2012;3:285–293
   Google Scholar
• Veeramani S, Chou YW, Lin FC, et al. Reactive oxygen species induced by p66Shc longevity protein mediate nongenomic androgen action via tyrosine phosphorylation signaling to enhance tumorigenicity of prostate cancer cells. Free Radic Biol Med. 2012;53:95–108
   Google Scholar
• Natalicchio A, Tortosa F, Perrini S, et al. p66Shc, a multifaceted protein linking Erk signalling, glucose metabolism, and oxidative stress. Arch Physiol Biochem. 2011;117:116–124
   PubMedGoogle Scholar
• Alam SM, Rajendran M, Ouyang S, et al. A novel role of Shc adaptor proteins in steroid hormone-regulated cancers. Endocr Relat Cancer. 2009;16:1–16
   Google Scholar
• Bashir M, Kirmani D, Bhat HF, et al. P66shc and its downstream Eps8 and Rac1 proteins are upregulated in esophageal cancers. Cell Commun Signal. 2010;8:13–18
   PubMedGoogle Scholar
• Carollo C, Lo Presti R, Caimi G. Leukocyte activation markers and oxidative status in chronic kidney disease. Minerva Urol Nefrol. 2013;65:69–76
   Google Scholar
• Fassett RG, Venuthurupalli SK, Gobe GC, et al. Biomarkers in chronic kidney disease: a review. Kidney Int. 2011;80:806–821
   PubMed Web of Science ®Google Scholar
• Gill PS, Wilcox CS. NADPH oxidases in the kidney. Antioxid Redox Signal. 2006;8:1597–1607
   PubMed Web of Science ®Google Scholar
• Percy CJ, Brown L, Power DA, et al. Obesity and hypertension have differing oxidant handling molecular pathways in age-related chronic kidney disease. Mech Ageing Dev. 2009;130:129–138
   PubMed Web of Science ®Google Scholar
• Kanwar YS, Sun L, Xie P, et al. A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol. 2011;6:395–423
   PubMed Web of Science ®Google Scholar
• Inoguchi T. Role of oxidative stress in pathogenesis of diabetic nephropathy. Nihon Jinzo Gakkai Shi. 2011;53:1016–1020
   Google Scholar
• Sun L, Xiao L, Nie J, et al. p66Shc mediates high-glucose and angiotensin II-induced oxidative stress renal tubular injury via mitochondrial-dependent apoptotic pathway. Am J Physiol Renal Physiol. 2010;299:F1014–F1025
   PubMed Web of Science ®Google Scholar
• Menini S, Iacobini C, Ricci C, et al. Ablation of the gene encoding p66Shc protects mice against AGE-induced glomerulopathy by preventing oxidant-dependent tissue injury and further AGE accumulation. Diabetologia. 2007;50:1997–2007
   PubMed Web of Science ®Google Scholar
• Pagnin E, Fadini G, de Toni R, et al. Diabetes induces p66shc gene expression in human peripheral blood mononuclear cells: relationship to oxidative stress. J Clin Endocrinol Metab. 2005;90:1130–1136
   PubMed Web of Science ®Google Scholar
• Bock F, Shahzad K, Wang H, et al. Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc. Proc Natl Acad Sci USA. 2013;110:648–653
   Google Scholar
• Abuelo JG. Normotensive ischemic acute renal failure. N Engl J Med. 2007;357:797–805
   PubMed Web of Science ®Google Scholar
• Chapman JR, O'Connell PJ, Nankivell BJ. Chronic renal allograft dysfunction. J Am Soc Nephrol. 2005;16:3015–3026
   PubMed Web of Science ®Google Scholar
• Safirstein RL. Lessons learned from ischemic and cisplatin-induced nephrotoxicity in animals. Ren Fail. 1999;21:359–364
   PubMed Web of Science ®Google Scholar
• Arany I, Megyesi JK, Kaneto H, et al. Activation of ERK or inhibition of JNK ameliorates H(2)O(2) cytotoxicity in mouse renal proximal tubule cells. Kidney Int. 2004;65:1231–1239
   Google Scholar
• Arany I, Megyesi JK, Reusch JE, Safirstein RL. CREB mediates ERK-induced survival of mouse renal tubular cells after oxidant stress. Kidney Int. 2005;68:1573–1582
   PubMedGoogle Scholar
• di Mari JF, Davis R, Safirstein RL. MAPK activation determines renal epithelial cell survival during oxidative injury. Am J Physiol. 1999;277:F195–F203
   Google Scholar
• Andreucci M, Michael A, Kramers C, et al. Renal ischemia/reperfusion and ATP depletion/repletion in LLC-PK(1) cells result in phosphorylation of FKHR and FKHRL1. Kidney Int. 2003;64:1189–1198
   Google Scholar
• Iordanov MS, Choi RJ, Ryabinina OP, et al. The UV (Ribotoxic) stress response of human keratinocytes involves the unexpected uncoupling of the Ras-extracellular signal-regulated kinase signaling cascade from the activated epidermal growth factor receptor. Mol Cell Biol. 2002;22:5380–5394
   PubMed Web of Science ®Google Scholar
• Wang Z, Chen JK, Wang SW, et al. Importance of functional EGF receptors in recovery from acute nephrotoxic injury. J Am Soc Nephrol. 2003;14:3147–3154
   PubMed Web of Science ®Google Scholar
• Yano T, Yazima S, Hagiwara K, et al. Activation of epidermal growth factor receptor in the early phase after renal ischemia--reperfusion in rat. Nephron. 1999;81:230–233
   Google Scholar
• Ravichandran KS. Signaling via Shc family adapter proteins. Oncogene. 2001;20:6322–6330
   PubMed Web of Science ®Google Scholar
• Rao GN. Hydrogen peroxide induces complex formation of SHC-Grb2-SOS with receptor tyrosine kinase and activates Ras and extracellular signal-regulated protein kinases group of mitogen-activated protein kinases. Oncogene. 1996;13:713–719
   PubMed Web of Science ®Google Scholar
• Pellegrini M, Pacini S, Baldari CT. p66SHC: the apoptotic side of Shc proteins. Apoptosis. 2005;10:13–18
   PubMed Web of Science ®Google Scholar
• Okada S, Kao AW, Ceresa BP, et al. The 66-kDa Shc isoform is a negative regulator of the epidermal growth factor-stimulated mitogen-activated protein kinase pathway. J Biol Chem. 1997;272:28042–28049
   PubMed Web of Science ®Google Scholar
• Purdom S, Chen QM. Linking oxidative stress and genetics of aging with p66Shc signaling and forkhead transcription factors. Biogerontology. 2003;4:181–191
   PubMedGoogle Scholar
• Skulachev VP. The p66shc protein: a mediator of the programmed death of an organism? IUBMB Life. 2000;49:177–180
   PubMedGoogle Scholar
• Arany I, Faisal A, Nagamine Y, Safirstein RL. p66shc inhibits pro-survival epidermal growth factor receptor/ERK signaling during severe oxidative stress in mouse renal proximal tubule cells. J Biol Chem. 2008;283:6110–6117
   PubMed Web of Science ®Google Scholar
• Arany I, Faisal A, Clark JS, et al. p66SHC-mediated mitochondrial dysfunction in renal proximal tubule cells during oxidative injury. Am J Physiol Renal Physiol. 2010;298:F1214–1221
   Google Scholar
• Barisoni L, Kriz W, Mundel P, D'Agati V. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol. 1999;10:51–61
   PubMed Web of Science ®Google Scholar
• Zhong J, Zuo Y, Ma J, et al. Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy. Kidney Int. 2005;68:1048–1060
   PubMed Web of Science ®Google Scholar
• Hu Y, Wang X, Zeng L, et al. ERK phosphorylates p66shcA on Ser36 and subsequently regulates p27kip1 expression via the Akt-FOXO3a pathway: implication of p27kip1 in cell response to oxidative stress. Mol Biol Cell. 2005;16:3705–3718
   PubMed Web of Science ®Google Scholar
• Husain M, Meggs LG, Vashistha H, et al. Inhibition of p66ShcA longevity gene rescues podocytes from HIV-1-induced oxidative stress and apoptosis. J Biol Chem. 2009;284:16648–16658
   Google Scholar
• Orth SR, Ritz E. The renal risks of smoking: an update. Curr Opin Nephrol Hypertens. 2002;11:483–488
   PubMed Web of Science ®Google Scholar
• Orth SR, Hallan SI. Smoking: a risk factor for progression of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients – absence of evidence or evidence of absence? Clin J Am Soc Nephrol. 2008;3:226–236
   PubMed Web of Science ®Google Scholar
• Halimi JM, Giraudeau B, Vol S, et al. Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population. Kidney Int. 2000;58:1285–1292
   PubMed Web of Science ®Google Scholar
• Rossing P, Hougaard P, Parving HH. Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study. Diabetes Care. 2002;25:859–864
   Web of Science ®Google Scholar
• Hallan SI, Orth SR. Smoking is a risk factor in the progression to kidney failure. Kidney Int. 2011;80:516–523
   PubMed Web of Science ®Google Scholar
• Agarwal PK, Hellemons ME, Zelle DM, et al. Smoking is a risk factor for graft failure and mortality after renal transplantation. Am J Nephrol. 2011;34:26–31
   Google Scholar
• Husain K, Scott BR, Reddy SK, Somani SM. Chronic ethanol and nicotine interaction on rat tissue antioxidant defense system. Alcohol. 2001;25:89–97
   PubMed Web of Science ®Google Scholar
• Orth SR. Smoking and the kidney. J Am Soc Nephrol. 2002;13:1663–1672
   PubMedGoogle Scholar
• Arany I, Clark J, Reed DK, Juncos LA. Chronic nicotine exposure augments renal oxidative stress and injury through transcriptional activation of p66shc. Nephrol Dial Transplant. 2013;28:1417–1425
   PubMed Web of Science ®Google Scholar
• Sigalotti L, Fratta E, Coral S, et al. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications. J Cell Physiol. 2007;212:330–344
   PubMed Web of Science ®Google Scholar
• Peterson BA, Collins AJ, Vogelzang NJ, Bloomfield CD. 5-Azacytidine and renal tubular dysfunction. Blood. 1981;57:182–185
   Google Scholar
• Kintzel PE. Anticancer drug-induced kidney disorders. Drug Saf. 2001;24:19–38
   PubMed Web of Science ®Google Scholar
• Gao S, Mobley A, Miller C, et al. Potentiation of reactive oxygen species is a marker for synergistic cytotoxicity of MS-275 and 5-azacytidine in leukemic cells. Leuk Res. 2008;32:771–780
   PubMed Web of Science ®Google Scholar
• Nadasi E, Clark JS, Szanyi I, et al. Epigenetic modifiers exacerbate oxidative stress in renal proximal tubule cells. Anticancer Res. 2009;29:2295–2299
   Google Scholar
• Ventura A, Luzi L, Pacini S, et al. The p66Shc longevity gene is silenced through epigenetic modifications of an alternative promoter. J Biol Chem. 2002;277:22370–22376
   PubMed Web of Science ®Google Scholar
• Arany I, Clark JS, Ember I, Juncos LA. Epigenetic modifiers exert renal toxicity through induction of p66shc. Anticancer Res. 2011;31:3267–3271
   Google Scholar
• Arany I, Safirstein RL. Cisplatin nephrotoxicity. Semin Nephrol. 2003;23:460–464
   PubMed Web of Science ®Google Scholar
• Hanigan MH, Devarajan P. Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther. 2003;1:47–61
   PubMedGoogle Scholar
• Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int. 2008;73:994–1007
   PubMed Web of Science ®Google Scholar
• Kim YK, Kim HJ, Kwon CH, et al. Role of ERK activation in cisplatin-induced apoptosis in OK renal epithelial cells. J Appl Toxicol. 2005;25:374–382
   PubMed Web of Science ®Google Scholar
• Nowak G. Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells. J Biol Chem. 2002;277:43377–43388
   PubMed Web of Science ®Google Scholar
• Jo SK, Cho WY, Sung SA, et al. MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis. Kidney Int. 2005;67:458–466
   PubMed Web of Science ®Google Scholar
• Obreztchikova M, Elouardighi H, Ho M, et al. Distinct signaling functions for Shc isoforms in the heart. J Biol Chem. 2006;281:20197–20204
   Google Scholar
• Clark JS, Faisal A, Baliga R, et al. Cisplatin induces apoptosis through the ERK-p66shc pathway in renal proximal tubule cells. Cancer Lett. 2010;297:165–170
   Google Scholar
• Arany I, Clark JS, Reed DK, et al. Cisplatin enhances interaction between p66Shc and HSP27: its role in reorganization of the actin cytoskeleton in renal proximal tubule cells. Anticancer Res. 2012;32:4759–4763
   PubMed Web of Science ®Google Scholar
• Rattanavich R, Plagov A, Kumar D, et al. Deficit of p66ShcA restores redox-sensitive stress response program in cisplatin-induced acute kidney injury. Exp Mol Pathol. 2013;94:445–452
   Google Scholar
• Toussaint ND. Extracellular matrix calcification in chronic kidney disease. Curr Opin Nephrol Hypertens. 2011;20:360–368
   Google Scholar
• Acloque H, Adams MS, Fishwick K, et al. Epithelial--mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest. 2009;119:1438–1449
   PubMed Web of Science ®Google Scholar
• Liu Y. New insights into epithelial--mesenchymal transition in kidney fibrosis. J Am Soc Nephrol. 2010;21:212–222
   PubMed Web of Science ®Google Scholar
• Zhang A, Jia Z, Guo X, Yang T. Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial origin. Am J Physiol Renal Physiol. 2007;293:F723–F731
   Google Scholar
• Hock MB, Kralli A. Transcriptional control of mitochondrial biogenesis and function. Annu Rev Physiol. 2009;71:177–203
   PubMed Web of Science ®Google Scholar
• Yuan Y, Chen Y, Zhang P, et al. Mitochondrial dysfunction accounts for aldosterone-induced epithelial-to-mesenchymal transition of renal proximal tubular epithelial cells. Free Radic Biol Med. 2012;53:30–43
   Google Scholar
• Sorokin A. Endothelin signaling and actions in the renal mesangium. Contrib Nephrol. 2011;172:50–62
   Google Scholar
• Foschi M, Franchi F, Han J, La Villa G, Sorokin A. Endothelin-1 induces serine phosphorylation of the adaptor protein p66Shc and its association with 14-3-3 protein in glomerular mesangial cells. J Biol Chem. 2001;276:26640–26647
   Google Scholar
• Chao DT, Korsmeyer SJ. BCL-2 family: regulators of cell death. Annu Rev Immunol. 1998;16:395–419
   PubMed Web of Science ®Google Scholar
• Nissenson AR. Acute renal failure: definition and pathogenesis. Kidney Int Suppl. 1998;66:S7–10
   PubMedGoogle Scholar
• Shichiri M, Yokokura M, Marumo F, Hirata Y. Endothelin-1 inhibits apoptosis of vascular smooth muscle cells induced by nitric oxide and serum deprivation via MAP kinase pathway. Arterioscler Thromb Vasc Biol. 2000;20:989–997
   PubMedGoogle Scholar
• Nangaku M, Couser WG. Mechanisms of immune-deposit formation and the mediation of immune renal injury. Clin Exp Nephrol. 2005;9:183–191
   PubMedGoogle Scholar
• Finetti F, Pellegrini M, Ulivieri C, et al. The proapoptotic and antimitogenic protein p66SHC acts as a negative regulator of lymphocyte activation and autoimmunity. Blood. 2008;111:5017–5027
   PubMed Web of Science ®Google Scholar
• Rajendran R, Garva R, Krstic-Demonacos M, Demonacos C. Sirtuins: molecular traffic lights in the crossroad of oxidative stress, chromatin remodeling, and transcription. J Biomed Biotechnol. 2011;2011:368276–368292
   PubMedGoogle Scholar
• Zhou S, Chen HZ, Wan YZ, et al. Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction. Circ Res. 2011;109:639–648
   PubMed Web of Science ®Google Scholar
• Xu Y, Nie L, Yin YG, et al. Resveratrol protects against hyperglycemia-induced oxidative damage to mitochondria by activating SIRT1 in rat mesangial cells. Toxicol Appl Pharmacol. 2012;259:395–401
   PubMed Web of Science ®Google Scholar
• Yang L, Bailey L, Baltimore D, Wang P. Targeting lentiviral vectors to specific cell types in vivo. Proc Natl Acad Sci USA. 2006;103:11479–11484
   Google Scholar
• Wang H, Ghosh A, Baigude H, et al. Therapeutic gene silencing delivered by a chemically modified small interfering RNA against mutant SOD1 slows amyotrophic lateral sclerosis progression. J Biol Chem. 2008;283:15845–15852
   PubMed Web of Science ®Google Scholar